Literature DB >> 25903722

Tumor border sharpness correlates with HLA-G expression in low-grade gliomas.

Yinyan Wang1, Xing Fan1, Hongming Li2, Zhiguo Lin3, Hongbo Bao3, Shaowu Li4, Lei Wang5, Tianzi Jiang2, Yong Fan6, Tao Jiang7.   

Abstract

Human leukocyte antigen-G (HLA-G) is a tumor microenvironment molecule that is involved in the escape of cancerous tumors from host immune recognition and destruction. This study investigated the potential relationship between HLA-G expression levels and the sharpness of low-grade glioma tumor borders in magnetic resonance images. Preoperative T2-weighted images from 72 patients were retrospectively examined by manually segmenting the hyperintensive tumor areas and subsequently registering them to a standard brain template. Then, the intensity of the voxels inside the tumor border (tumor voxels) was compared with that of the voxels outside the tumor border (paratumor voxels). The radiologic sharpness of a tumor was defined as the mean ratio of the intensity of the tumor voxels to the intensity of the paratumor voxels. Tumors with high HLA-G expression were associated with larger tumors and lower mean hyperintensive contrast. These findings suggest that tumors with blurred boundaries may be those prone to diffuse invasion. Additionally, patients with tumors having high HLA-G expression were less likely to have undergone complete resections. Thus, this study is the first to identify an association between HLA-G expression and the radiologic morphology of the tumor border, and may further our understanding of the role of the HLA gene in immune escape in patients with low-grade gliomas.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HLA-G; Low-grade glioma; Sharpness of the tumor border

Mesh:

Substances:

Year:  2015        PMID: 25903722     DOI: 10.1016/j.jneuroim.2015.02.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

2.  MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.

Authors:  Yiming Li; Xing Liu; Kaibin Xu; Zenghui Qian; Kai Wang; Xing Fan; Shaowu Li; Yinyan Wang; Tao Jiang
Journal:  Eur Radiol       Date:  2017-07-28       Impact factor: 5.315

3.  Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.

Authors:  Yiming Li; Xing Liu; Zenghui Qian; Zhiyan Sun; Kaibin Xu; Kai Wang; Xing Fan; Zhong Zhang; Shaowu Li; Yinyan Wang; Tao Jiang
Journal:  Eur Radiol       Date:  2018-02-05       Impact factor: 5.315

4.  MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.

Authors:  Yiming Li; Zenghui Qian; Kaibin Xu; Kai Wang; Xing Fan; Shaowu Li; Tao Jiang; Xing Liu; Yinyan Wang
Journal:  Neuroimage Clin       Date:  2017-10-29       Impact factor: 4.881

5.  Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.

Authors:  Mohammad Hassan Heidari; Abolfazl Movafagh; Mohammad-Amin Abdollahifar; Shabnam Abdi; Mohamadreza Mashhoudi Barez; Hadi Azimi; Afshin Moradi; Amin Bagheri; Matineh Heidari; Jafar Hessam Mohseni; Maryam Tadayon; Hoda Mirsafian; Mahdi Ghatrehsamani
Journal:  Anat Cell Biol       Date:  2017-03-29

6.  Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach.

Authors:  Shengyu Fang; Ziwen Fan; Zhiyan Sun; Yiming Li; Xing Liu; Yuchao Liang; Yukun Liu; Chunyao Zhou; Qiang Zhu; Hong Zhang; Tianshi Li; Shaowu Li; Tao Jiang; Yinyan Wang; Lei Wang
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

Review 7.  Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.

Authors:  Fabio Morandi; Roberta Rizzo; Enrico Fainardi; Nathalie Rouas-Freiss; Vito Pistoia
Journal:  J Immunol Res       Date:  2016-08-29       Impact factor: 4.818

8.  HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival.

Authors:  Zhifeng Wu; Jingshan Liang; Zheng Wang; Aimin Li; Xing Fan; Tao Jiang
Journal:  BMC Neurol       Date:  2020-02-17       Impact factor: 2.474

Review 9.  HLA-G Neo-Expression on Tumors.

Authors:  Maria Loustau; François Anna; Raphaelle Dréan; Martin Lecomte; Pierre Langlade-Demoyen; Julien Caumartin
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

Review 10.  Deregulation of HLA-I in cancer and its central importance for immunotherapy.

Authors:  Ahmet Hazini; Kerry Fisher; Len Seymour
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.